TASE ends Sunday mixed, though telco shares plunge
EU approval of drug for treating chemotherapy side-effects lifts Teva by just under 3%
Tel Aviv shares finished mixed on Sunday, with Teva Pharmaceuticals and Israel Chemicals ending strongly higher while technology and telecommunications stocks plunged.
register with haaretz
Like us on Facebook and get articles directly in your news feed